Management of Advanced HER2+ Breast Cancer - Episode 5

Investigational Agents, Clinical Trials for Advanced HER2+ Breast Cancer

,

Joyce A. O’Shaughnessy, MD, and Neil M. Iyengar, MD, discuss novel agents in the pipeline for patients with advanced HER2-positive breast cancer.